DOSAGE REDUCTION OF LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL DYSFUNCTION: EFFECTS ON ANTI-XA LEVELS AND CLINICAL OUTCOMES

被引：0
|
作者：
Hornung, Paul [1 ]
Khairoun, Meriem [1 ]
Dekker, Friedo W. [2 ]
Kaasjager, Karin A. H. [3 ]
Huisman, Albert [4 ]
Jakulj, Lily [5 ,6 ]
Bos, Willem Jan [7 ,8 ]
Rosendaai, Frits [2 ]
Verhaar, Marianne [1 ]
Ocak, Gurbey [1 ,2 ,7 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands
[2] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands
[3] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
[5] Univ Amsterdam, Dianet Dialysis Ctr, Med Ctr, Amsterdam, Netherlands
[6] Dept Nephrol, Amsterdam, Netherlands
[7] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands
[8] Leiden Univ, Dept Internal Med, Med Ctr, Leiden, Netherlands
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
P0810
引用
收藏
页码：1141 / 1141
页数：1
相关论文
共 50 条
  • [31] Monitoring of Anti-Xa in Pregnant Patients With Mechanical Prosthetic Valves Receiving Low-Molecular-Weight Heparin: Peak or Trough Levels?
    Goland, Sorel
    Schwartzenberg, Shmuel
    Fan, John
    Kozak, Natasha
    Khatri, Nudrat
    Elkayam, Uri
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (05) : 451 - 456
  • [32] Audit of low molecular weight heparin dosing and anti-Xa monitoring in paediatric patients in the University Hospitals of Leicester
    Tsoulkani, A.
    Gooding, R. C.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 99 - 99
  • [33] Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review
    Kjaergaard, Amalie Baun
    Fuglsang, Jens
    Hvas, Anne-Mette
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2021, 47 (07): : 824 - 842
  • [34] Should low molecular weight heparin dosing be based on anti-Xa assays in antiphospholipid syndrome?
    Thachil, Jecko
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2013, 24 (01) : 82 - 84
  • [35] SAFETY AND PLASMA ANTI-XA LEVELS OF LOW-MOLECULAR-WEIGHT HEPARIN INITIATED PRIOR TO STREPTOKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    GORANSSON, L
    NILSEN, DWT
    LARSEN, AI
    HETLAND, O
    SULILA, P
    [J]. THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 648 - 648
  • [36] The effect of 3.2% vs 3.8% sodium citrate concentration on chromogenic anti-Xa low molecular weight heparin levels.
    Galal, A
    MacKinnon, K
    Keeney, M
    Kovacs, MJ
    [J]. BLOOD, 1999, 94 (10) : 105B - 105B
  • [37] Higher doses of low molecular weight heparin (LMWH) are needed to achieve goal Anti-Xa levels in critically ill children
    Schloemer, N. J.
    Abu-Sultaneh, S.
    Hanson, S.
    Yan, K.
    Hoffmann, R. G.
    Punzalan, R.
    Havens, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 93 - 93
  • [38] INCREASED ANTI-XA BIOAVAILABILITY FOR A LOW-MOLECULAR WEIGHT HEPARIN (PK-10169) COMPARED WITH UNFRACTIONATED HEPARIN
    BARA, L
    BILLAUD, E
    KHER, A
    SAMAMA, M
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (03): : 316 - 317
  • [39] THE LACK OF RELATIONSHIP BETWEEN ANTI-XA ACTIVITY AND ANTITHROMBOTIC ACTIVITY OF LOW-MOLECULAR WEIGHT HEPARIN
    OCKELFORD, PA
    CARTER, CJ
    HIRSH, J
    [J]. THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 116 - 116
  • [40] Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
    Xu, Lengnan
    Sun, Ying
    Wang, Songlan
    Li, Chuanbao
    Mao, Yonghui
    [J]. ANNALS OF HEMATOLOGY, 2023, 102 (08) : 2251 - 2256
12345